Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study

NCT00129441 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Merck L-830982
DRUG: Placebo

Sponsor

University of Pittsburgh

Collaborators

[object Object]